25th Jun 2025 Plain language summary: ECHELON-3 study results on using brentuximab vedotin combination therapy for diffuse large B-cell lymphoma patients
25th Jun 2025 Plain language summary: effectiveness and safety of larotrectinib in lung cancer patients with TRK fusion mutations – results from two trials
30th Jul 2024 Plain language summary of Trifluridine/Tipiracil and Bevacizumab for refractory metastatic colorectal cancer: The SUNLIGHT Study
